Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSource International was a prominent life science company specializing in the development and manufacture of reagents for functional genomics, proteomics, and drug discovery. The company offered an extensive portfolio of antibodies, ELISA kits, cytokines, and growth factors, with a particular focus on phosphorylation-specific antibodies and multiplex assays for cell signaling research. BioSource's products were widely utilized by academic and pharmaceutical researchers to investigate disease pathways in oncology, immunology, and neurobiology. In 2005, the company was acquired by Invitrogen, which subsequently became part of Thermo Fisher Scientific, where the BioSource product line continues to support protein analysis and cell biology applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosource.